Association of FVC and total mortality in US adults with metabolic syndrome and diabetes

Chest

Volumn 136, Issue 1, 2009, Pages 171-176

  Lee, Hwa Mu ^a   Chung, Sarah J ^a   Lopez, Victor A ^a   Wong, Nathan D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

EID: 67650796363     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1901     Document Type: Article

References (40)

1. Saydah SH, Eberhardt MS, Loria CM, et al. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 2002; 156:714-719
2. Cho E, Rimm EB, Stampfer MJ, et al. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002; 40:954-960
3. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110:1245-1250
4. Kaseta J, Sowers JR. Diabetes and the metabolic syndrome. In: Wong ND, Black HR, Gardin JM, eds. Preventive cardiology: a practical approach. New York, NY: McGraw-Hill, 2005; 212-232
5. Higgins MW, Keller JB. Predictors of mortality in the adult population of Tecumseh. Arch Environ Health 1970; 21:418-424
6. Beaty TH, Newill CA, Cohen BH, et al. Effects of pulmonary function on mortality. J Chronic Dis 1985; 38:703-710
7. Tockman MS, Comstock GW. Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland. Am Rev Respir Dis 1989; 140(suppl):S56-S63
8. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313:711-715
9. Schünemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118:656-664
10. Curb JD, Marcus EB, Reed DM, et al. Smoking, pulmonary function, and mortality. Ann Epidemiol 1990; 1:25-32
11. Lange P, Nyboe J, Appleyard M, et al. Spirometric findings and mortality in never-smokers. J Clin Epidemiol 1990; 43: 867-873
12. Schuyler MR, Niewoehner DE, Inkley SR, et al. Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 1976; 113:37-41
13. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004; 47:195-203
14. Lazarus R, Sparrow D, Weiss ST. Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: the Normative Aging Study. Eur Respir J 1998; 12:641-645
15. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study. Diabetes Care 2004; 27: 2966 -2970
16. Yeh HC, Punjabi NM, Wang NY, et al. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005; 28:1472-1479
17. Engström G, Hedblad B, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003; 253:574-581
18. Centers for Disease Control and Prevention, National Center for Health Statistics. Third National Health and Nutrition Examination Survey data. Hyattsville, MD: US Department of Health and Human Services, Centers for disease Control and Prevention, 1988-1994
19. Bernert JT, Turner WE, Pirkle JL, et al. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/ atmospheric pressure ionization tandem mass spectrometry. Clin Chem 1997; 43:2281-2291
20. Centers for Disease Control and Prevention, National Center for Health Statistics. Third National Health and Nutrition Examination Survey laboratory/medical technologists procedures and manual. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, 1988-1994
21. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159:179-187
22. Centers for Disease Control and Prevention, National Center for Health Statistics. Third National Health and Nutrition Examination linked mortality file: matching methodology. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2005
23. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752
24. SAS Institute. SAS Procedure Guide, version 6.12. 3rd ed. Cary, NC: SAS Institute, 1995
25. Lee HM, Le TV, Lopez VA, et al. Association of C-reactive protein with reduced forced vital capacity in a nonsmoking US population with metabolic syndrome and diabetes. Diabetes Care 2008; 30:2000-2002
26. Sin DD, Wu L, Man SFP. The relationship between reduced lung function and cardiovascular mortality: a populationbased study and a systematic review of the literature. Chest 2005; 127:1952-1959
27. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-334
28. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001; 50:2384-2389
29. Han TS, Sattar N, Williams K, et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002; 25:2016-2021
30. Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2004; 2:82-104
31. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683-689
32. Guize L, Thomas F, Pannier B, et al. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care 2007; 30:2381-2387
33. Knuiman MW, Welborn TA, Whittall DE. An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiol 1992; 135: 638-648
34. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 1998; 21:1138-1145
35. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10 year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Clin Epidemiol 1988; 41:251-260
36. Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003; 158:1171-1181
37. Rossi A, Fantin F, Di Francesco V, et al. Body composition and pulmonary function in the elderly: a 7-year longitudinal study. Int J Obes 2008; 32:1423-1430
38. Thyagarajan B, Jacobs DR, Apostol GG, et al. Longitudinal association of body mass index with lung function: the CARDIA Study. Respir Res 2008; 9:31
39. Cohen BH. Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am J Epidemiol 1980; 112: 274-288
40. Suwa T, Hogg JC, Quinlan KB, et al. Particulate air pollution induces progression of atherosclerosis. Am J Cardiol 2002; 39:935-942